市场消息：马来西亚贸易部长向议会通报了与美国的关税谈判情况。马来西亚贸易部长称，同意削减或 取消美国98.4%关税细目的进口关税，并将豁免部分美国农产品（如水果、海鲜）的销售税。美国方面 希望马来西亚增加采购和投资以缩小贸易逆差。 ...

Core Insights - Malaysia's Minister of Trade announced that Petronas, the national oil company of Malaysia, will purchase liquefied natural gas (LNG) from the United States valued at $3.4 billion annually [1] Company Summary - Petronas will engage in significant annual purchases of LNG, indicating a strong commitment to sourcing energy from the U.S. market [1] Industry Summary - The deal highlights the growing importance of U.S. LNG in the global energy market, particularly for countries like Malaysia that are looking to diversify their energy sources [1]

Core Viewpoint - Jefferies reports that Innoscience has significant long-term upside potential, maintaining a "Buy" rating with a target price of HKD 54.29 [1] Group 1: Market Potential - Jefferies estimates the Total Addressable Market (TAM) for Innoscience's NV72 (based on GB200) to be approximately USD 1.5 billion, and USD 2.5 billion when including ASICs from cloud service providers [1] - Assuming a 50% market share for Innoscience, with a net profit margin of 25%, the recent market capitalization increase of USD 1.5 billion reflects only a 5x price-to-earnings ratio of potential profits from AI servers [1] Group 2: Future Projections - Jefferies anticipates that mass production will begin in 2027, although the quantifiable potential is still considered premature as the 800VDC architecture and Ruben chip design have not been finalized [1] - The firm acknowledges that further profit-taking after the recent price surge would not be unexpected [1]

马来西亚贸易部长：马来西亚将在五年内采购价值1500亿美元的美国半导体、航空航天和数据中心领域 产品。 ...

A股创新药概念股局部反弹，翰宇药业午后直线拉升涨超10%，海辰药业、阳光诺和、广生堂涨超 10%，福源医药、万泽股份涨停，陇神戎发、京新药业、常山药业、舒泰神等跟涨。 ...

Core Viewpoint - Sanofi has confirmed the cessation of the supply of its drug, Praluent (alirocumab injection), in the Chinese market due to global supply issues and a strategic upgrade in its cardiovascular product offerings in China [1] Group 1: Supply and Strategic Changes - The decision to stop supplying Praluent is attributed to global supply challenges [1] - Sanofi is upgrading its cardiovascular product strategy in China, which includes a partnership with Jinxing Pharmaceutical for Aficamten and acquiring rights for the investigational drug, Plerixafor [1] - The company emphasizes its commitment to continue providing a range of products to meet the needs of domestic patients [1]

Group 1 - The satellite industry ETF (159218) increased by over 3% with a trading volume of 7.0551 million yuan, representing a 22.62% increase compared to the same time yesterday [1]

Core Viewpoint - Zhejiang Province has successfully developed a path of green high-quality development over the past 20 years, balancing economic transformation, environmental improvement, and urban-rural harmony, becoming the first ecological province in China [1] Group 1: Achievements - The "Million Project," "Ant Forest," and "Blue Cycle" initiatives have received the United Nations' highest environmental honor, the "Earth Guardian Award" [1] - The province has focused on two main objectives: protecting beautiful mountains and rivers, and expanding economic wealth [1]

Core Viewpoint - Citigroup has raised its gold price forecast for the next three months from $3,300 to $3,500 per ounce, citing deteriorating growth and inflation outlooks for the U.S. economy [1] Economic Outlook - The bank anticipates that concerns over U.S. economic growth and tariff-related inflation will continue to escalate in the second half of 2025 [1] - A weakening dollar is expected to contribute to a moderate increase in gold prices, potentially reaching historical highs [1] Employment and Geopolitical Risks - Weak U.S. employment data in Q2 2025 is likely to heighten concerns regarding the credibility of the Federal Reserve and U.S. statistical data [1] - Rising geopolitical risks associated with the Russia-Ukraine conflict are also noted as a factor influencing gold prices [1] Demand for Gold - Since mid-2022, total demand for gold has increased by over one-third [1]

Core Viewpoint - Nomura analysts predict that BYD's delivery volume this year may range between 5 million to 5.2 million vehicles [1] Group 1 - The potential delivery volume for BYD is estimated to be between 5 million and 5.2 million vehicles for the year [1] - The company may introduce new models or upgrade existing ones, which could provide some bottom-up opportunities for BYD [1]